Ellen van Ommen

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

T. Rabelink, P. van Paassen, C. van Kooten, 2022, Trials.